Literature DB >> 18366979

Noninvasive adrenal imaging in hyperaldosteronism.

Daniel R Simon1, Michael A Palese.   

Abstract

Proper management of primary aldosteronism requires localization of excess aldosterone production. Partial or radical adrenalectomy may cure cases of aldosterone-producing adenomas; however, pharmacologic management is indicated in cases of bilateral adrenal hyperplasia. Differentiating among the causes of primary aldosteronism can be a diagnostic challenge. Adrenal vein sampling, the gold standard for diagnosing subtypes of primary aldosteronism, is an invasive and often difficult procedure. Advancements in CT and MRI have improved their adrenal-imaging capabilities, but accuracy in identifying aldosterone-producing adenomas remains inferior to adrenal vein sampling. Radionuclide scintigraphy has been used for many years and can also provide functional information for diagnosis. No diagnostic test, however, distinguishes with complete accuracy aldosterone-producing adenomas from bilateral adrenal hyperplasia in primary aldosteronism. Therefore, a combination of diagnostic techniques may most effectively guide medical management.

Entities:  

Mesh:

Year:  2008        PMID: 18366979     DOI: 10.1007/s11934-008-0015-2

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  40 in total

1.  Primary aldosteronism.

Authors:  J W CONN
Journal:  J Lab Clin Med       Date:  1955-04

2.  Primary aldosteronism: diagnosis, localization, and treatment.

Authors:  M H Weinberger; C E Grim; J W Hollifield; D C Kem; A Ganguly; N J Kramer; H Y Yune; H Wellman; J P Donohue
Journal:  Ann Intern Med       Date:  1979-03       Impact factor: 25.391

3.  Value of bowel preparation in adrenocortical scintigraphy with NP-59.

Authors:  B Shapiro; M Nakajo; M D Gross; J Freitas; J Copp; W H Beierwaltes
Journal:  J Nucl Med       Date:  1983-08       Impact factor: 10.057

4.  Primary hyperaldosteronism (Conn syndrome): MR imaging findings.

Authors:  S A Sohaib; P D Peppercorn; C Allan; J P Monson; A B Grossman; G M Besser; R H Reznek
Journal:  Radiology       Date:  2000-02       Impact factor: 11.105

5.  Adrenal adenomas: relationship between histologic lipid-rich cells and CT attenuation number.

Authors:  Takayuki Yamada; Tadashi Ishibashi; Haruo Saito; Toshio Matsuhashi; Kazuhiro Majima; Masashi Tsuda; Shoki Takahashi; Takuya Moriya
Journal:  Eur J Radiol       Date:  2003-11       Impact factor: 3.528

6.  CT of primary hyperaldosteronism (Conn's syndrome): the value of measuring the adrenal gland.

Authors:  R K Lingam; S A Sohaib; I Vlahos; A G Rockall; A M Isidori; J P Monson; A Grossman; R H Reznek
Journal:  AJR Am J Roentgenol       Date:  2003-09       Impact factor: 3.959

7.  Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

Authors:  Paolo Mulatero; Michael Stowasser; Keh-Chuan Loh; Carlos E Fardella; Richard D Gordon; Lorena Mosso; Celso E Gomez-Sanchez; Franco Veglio; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

8.  Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism.

Authors:  J E Freitas; R J Grekin; J H Thrall; M D Gross; D P Swanson; W H Beierwaltes
Journal:  J Nucl Med       Date:  1979-01       Impact factor: 10.057

9.  Diagnosis of primary hyperaldosteronism: importance of correlating CT findings with endocrinologic studies.

Authors:  D R Radin; C Manoogian; J L Nadler
Journal:  AJR Am J Roentgenol       Date:  1992-03       Impact factor: 3.959

10.  Scintigraphic localization of adrenal lesions in primary aldosteronism.

Authors:  M D Gross; B Shapiro; R J Grekin; J E Freitas; G Glazer; W H Beierwaltes; N W Thompson
Journal:  Am J Med       Date:  1984-11       Impact factor: 4.965

View more
  4 in total

1.  Outcome of surgical treatment of primary aldosteronism.

Authors:  Marilisa Citton; Giovanni Viel; Gian Paolo Rossi; Franco Mantero; Donato Nitti; Maurizio Iacobone
Journal:  Langenbecks Arch Surg       Date:  2015-01-08       Impact factor: 3.445

2.  Reversible sympathetic overactivity in hypertensive patients with primary aldosteronism.

Authors:  Andrew C Kontak; Zhongyun Wang; Debbie Arbique; Beverley Adams-Huet; Richard J Auchus; Shawna D Nesbitt; Ronald G Victor; Wanpen Vongpatanasin
Journal:  J Clin Endocrinol Metab       Date:  2010-07-21       Impact factor: 5.958

3.  Surgical outcomes of patients with primary aldosteronism lateralized with I-131-6 β-iodomethyl-norcholesterol single photon emission/computed tomography without discontinuation or modification of antihypertensive medications.

Authors:  Chia-Hui Chang; Stephen Shei-Dei Yang; Yao-Chou Tsai; Shi-Wen Kuo; Shiou-Chi Cherng; Ching-Chu Lu; Ruoh-Fang Yen; Vin-Cent Wu; Ya-Hui Hu
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2018 Jul-Sep

4.  A Rare Aldosterone-Producing Adenoma Detected by 68Ga-pentixafor PET-CT: A Case Report and Literature Review.

Authors:  Yunying Cui; Yushi Zhang; Jie Ding; Huiping Wang; Xiaoshen Ma; Ou Wang; Xiaoyan Chang; Hao Sun; Li Huo; Anli Tong
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-29       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.